vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and WEST BANCORPORATION INC (WTBA). Click either name above to swap in a different company.
WEST BANCORPORATION INC is the larger business by last-quarter revenue ($26.9M vs $20.0M, roughly 1.3× AGIOS PHARMACEUTICALS, INC.). WEST BANCORPORATION INC runs the higher net margin — 39.2% vs -541.1%, a 580.3% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 16.6%). WEST BANCORPORATION INC produced more free cash flow last quarter ($12.4M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 17.3%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
West Bancorporation Inc. is a regional financial holding company headquartered in the U.S. Midwest, primarily serving markets across Iowa and Minnesota. It provides a full suite of personal and commercial banking services, including deposit accounts, mortgage loans, business lending, and wealth management solutions for individual consumers, small-to-medium enterprises, and local organizational clients.
AGIO vs WTBA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $26.9M |
| Net Profit | $-108.0M | $10.6M |
| Gross Margin | 90.6% | — |
| Operating Margin | -608.9% | 50.0% |
| Net Margin | -541.1% | 39.2% |
| Revenue YoY | 86.1% | 16.6% |
| Net Profit YoY | -11.9% | 34.8% |
| EPS (diluted) | $-1.86 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $26.9M | ||
| Q4 25 | $20.0M | $24.2M | ||
| Q3 25 | $12.9M | $25.0M | ||
| Q2 25 | $12.5M | $23.8M | ||
| Q1 25 | $8.7M | $23.1M | ||
| Q4 24 | $10.7M | $20.9M | ||
| Q3 24 | $9.0M | $20.3M | ||
| Q2 24 | $8.6M | $19.6M |
| Q1 26 | — | $10.6M | ||
| Q4 25 | $-108.0M | $7.4M | ||
| Q3 25 | $-103.4M | $9.3M | ||
| Q2 25 | $-112.0M | $8.0M | ||
| Q1 25 | $-89.3M | $7.8M | ||
| Q4 24 | $-96.5M | $7.1M | ||
| Q3 24 | $947.9M | $6.0M | ||
| Q2 24 | $-96.1M | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — |
| Q1 26 | — | 50.0% | ||
| Q4 25 | -608.9% | 39.6% | ||
| Q3 25 | -907.4% | 45.8% | ||
| Q2 25 | -1020.1% | 43.4% | ||
| Q1 25 | -1222.0% | 43.4% | ||
| Q4 24 | -1165.3% | 30.9% | ||
| Q3 24 | -1146.9% | 36.6% | ||
| Q2 24 | -1228.3% | 32.6% |
| Q1 26 | — | 39.2% | ||
| Q4 25 | -541.1% | 30.7% | ||
| Q3 25 | -803.1% | 37.3% | ||
| Q2 25 | -899.4% | 33.5% | ||
| Q1 25 | -1023.3% | 34.0% | ||
| Q4 24 | -899.6% | 34.0% | ||
| Q3 24 | 10574.7% | 29.3% | ||
| Q2 24 | -1115.7% | 26.5% |
| Q1 26 | — | $0.61 | ||
| Q4 25 | $-1.86 | $0.44 | ||
| Q3 25 | $-1.78 | $0.55 | ||
| Q2 25 | $-1.93 | $0.47 | ||
| Q1 25 | $-1.55 | $0.46 | ||
| Q4 24 | $-1.44 | $0.41 | ||
| Q3 24 | $16.22 | $0.35 | ||
| Q2 24 | $-1.69 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $362.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $270.7M |
| Total Assets | $1.3B | $4.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $362.0M | ||
| Q4 25 | $89.1M | $471.1M | ||
| Q3 25 | $92.7M | $232.9M | ||
| Q2 25 | $80.9M | $345.2M | ||
| Q1 25 | $79.0M | — | ||
| Q4 24 | $76.2M | $243.5M | ||
| Q3 24 | $253.7M | — | ||
| Q2 24 | $84.5M | — |
| Q1 26 | — | $270.7M | ||
| Q4 25 | $1.2B | $266.0M | ||
| Q3 25 | $1.3B | $255.1M | ||
| Q2 25 | $1.4B | $240.9M | ||
| Q1 25 | $1.5B | $237.9M | ||
| Q4 24 | $1.5B | $227.9M | ||
| Q3 24 | $1.6B | $235.4M | ||
| Q2 24 | $660.5M | $223.9M |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $1.3B | $4.1B | ||
| Q3 25 | $1.4B | $4.0B | ||
| Q2 25 | $1.5B | $4.1B | ||
| Q1 25 | $1.6B | $4.0B | ||
| Q4 24 | $1.7B | $4.0B | ||
| Q3 24 | $1.8B | $4.0B | ||
| Q2 24 | $773.1M | $4.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $12.9M |
| Free Cash FlowOCF − Capex | $-97.3M | $12.4M |
| FCF MarginFCF / Revenue | -487.5% | 46.0% |
| Capex IntensityCapex / Revenue | 5.6% | 1.8% |
| Cash ConversionOCF / Net Profit | — | 1.22× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $79.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $12.9M | ||
| Q4 25 | $-96.2M | $46.5M | ||
| Q3 25 | $-88.2M | $11.4M | ||
| Q2 25 | $-77.1M | $13.5M | ||
| Q1 25 | $-111.5M | $9.7M | ||
| Q4 24 | $-133.2M | $39.8M | ||
| Q3 24 | $-84.2M | $12.9M | ||
| Q2 24 | $-72.6M | $10.0M |
| Q1 26 | — | $12.4M | ||
| Q4 25 | $-97.3M | $43.2M | ||
| Q3 25 | $-89.7M | $10.8M | ||
| Q2 25 | $-78.0M | $12.8M | ||
| Q1 25 | $-112.3M | $8.3M | ||
| Q4 24 | $-134.1M | $13.7M | ||
| Q3 24 | $-84.6M | $7.0M | ||
| Q2 24 | $-72.7M | $2.7M |
| Q1 26 | — | 46.0% | ||
| Q4 25 | -487.5% | 178.3% | ||
| Q3 25 | -696.5% | 43.0% | ||
| Q2 25 | -626.2% | 53.6% | ||
| Q1 25 | -1286.4% | 35.7% | ||
| Q4 24 | -1250.1% | 65.6% | ||
| Q3 24 | -944.2% | 34.2% | ||
| Q2 24 | -844.4% | 14.0% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | 5.6% | 13.7% | ||
| Q3 25 | 12.1% | 2.6% | ||
| Q2 25 | 7.0% | 3.2% | ||
| Q1 25 | 8.8% | 6.5% | ||
| Q4 24 | 9.0% | 125.3% | ||
| Q3 24 | 4.7% | 29.4% | ||
| Q2 24 | 1.8% | 37.1% |
| Q1 26 | — | 1.22× | ||
| Q4 25 | — | 6.26× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.70× | ||
| Q1 25 | — | 1.24× | ||
| Q4 24 | — | 5.61× | ||
| Q3 24 | -0.09× | 2.17× | ||
| Q2 24 | — | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
